Observation of the effects of cytokine adsorbent hemadsorption therapy on hemodynamics and mortality in critically ill patients who developed vasoplegic shock due to hyperinflammation without microbiological findings in the intensive care unit.
Observation of the effects of cytokine adsorbent hemadsorption therapy on hemodynamics and mortality in critically ill patients who developed vasoplegic shock due to hyperinflammation without microbiological findings and met the inclusion criteria in the Intensive Care Unit between 01.08.2023 and 01.02.2024
Study Type
OBSERVATIONAL
Enrollment
30
Observation of cytokine hemadsorption therapy in critically ill patients who have no microbiological findings and develop vasoplegic shock.
Prof. Dr. Cemil Taşcıoğlu City Hospital
Istanbul, Şişli, Turkey (Türkiye)
The time to resolution of vasoplegic shock within days.
Time frame: From enrollment to the end of treatment at 12 weeks
7-day mortality
Time frame: 7 days
mortality until discharge from hospital
Time frame: From enrollment to the end of treatment at 12 weeks
Interleukin 1 beta level on day 1
Time frame: one day
Interleukin 10 level on day 1
Time frame: one day
Interleukin 6 level on day 1
Time frame: one day
TNF - α level on day 1
Time frame: one day
Interleukin 1 beta level on day 3
Time frame: 3 days
Interleukin 10 level on day 3
Time frame: 3 days
Interleukin 6 level on day 3
Time frame: 3 days
TNF - α level on day 3
Time frame: 3 days
mechanical ventilation need and duration
Time frame: From enrollment to the end of treatment at 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
duration of treatment in the intensive care unit
Time frame: From enrollment to the end of treatment at 12 weeks
dose of catecholamine
Time frame: From enrollment to the end of treatment at 12 weeks